Hong Kong's Office for Attracting Strategic Enterprises (OASES) has unveiled its sixth batch of key enterprises, featuring major names such as Pfizer, Hengrui Medicine, and Cobo Fintech HK Limited. The announcement, made on April 20, highlights the inclusion of diverse companies from pharmaceuticals to digital asset custody and fintech. Financial Secretary Paul Chan stated that the 124 key enterprises are expected to bring HKD 73 billion in investments and create 25,000 new jobs. He noted that 75% of these companies plan to establish regional or international headquarters in Hong Kong, with 90% setting up research centers. Many firms are also interested in the Northern Metropolis area.